Atlas Trials

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

Clinical trial NCT06045780 · UNKNOWN

Trial details

NCT number
NCT06045780
Sponsor
Tianjin Nankai Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Sepsis
Start date
2023-09-15
Primary completion
2024-09-15
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.